Polyphosphate accelerates factor V activation by factor XIa

Thrombosis and Haemostasis

Volumn 113, Issue 3, 2015, Pages 599-604

  Choi, Sharon H ^a   Smith, Stephanie A ^a   Morrissey, James H ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Factor V; Factor XI; Polyphosphate; Prothrombinase

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; POLYMER; POLYPHOSPHATE; PROCOAGULANT; PROTHROMBIN; RIVAROXABAN; STREPTAVIDIN; THROMBOCYTE CONCENTRATE; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISSOCIATION CONSTANT; FIBRINOLYSIS; HEAVY CHAIN; HEMOSTASIS; HUMAN; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SURFACE PLASMON RESONANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; WESTERN BLOTTING; BLOOD; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; KINETICS; METABOLISM; THROMBOCYTE;

BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FACTOR V; FACTOR XIA; HEMOSTASIS; HUMANS; KINETICS; MOLECULAR WEIGHT; POLYPHOSPHATES; PROTEIN BINDING;

EID: 84925310761     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-06-0515     Document Type: Article

References (33)

1. Esmon CT. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem 1979; 254: 964–973.
2. Nesheim ME, Myrmel KH, Hibbard L, et al. Isolation and characterization of single chain bovine factor V. J Biol Chem 1979; 254: 508–517.
3. Jenny RJ, Pittman DD, Toole JJ, et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846–4850.
4. Monkovic DD, Tracy PB. Activation of human factor V by factor Xa and throm-bin. Biochemistry 1990; 29: 1118–1128.
5. Foster WB, Nesheim ME, Mann KG. The factor Xa-catalyzed activation of factor V. J Biol Chem 1983; 258: 13970–13977.
6. Suzuki K, Dahlback B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556–6564.
7. Owen CA, Jr., Cooper T. Parahemophilia. Arch Intern Med 1955; 95: 194–201.
8. Rosing J, Tans G, Govers-Riemslag J W, et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274–283.
9. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952–10962.
10. Kane WH, Majerus P W. Purification and characterization of human coagulation factor V. J Biol Chem 1981; 256: 1002–1007.
11. Bradford HN, Annamalai A, Doshi K, et al. Factor V is activated and cleaved by platelet calpain: comparison with thrombin proteolysis. Blood 1988; 71: 388–394.
12. Samis JA, Garrett M, Manuel RP, et al. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V. Blood 1997; 90: 1065–1074.
13. Camire RM, Kalafatis M, Tracy PB. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding. Biochemistry 1998; 37: 11896–11906.
14. Safa O, Morrissey JH, Esmon CT, et al. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C. Biochemistry 1999; 38: 1829–1837.
15. Kane WH, Mruk JS, Majerus P W. Activation of coagulation factor V by a platelet protease. J Clin Invest 1982; 70: 1092–1100.
16. Whelihan MF, Orfeo T, Gissel MT, et al. Coagulation procofactor activation by factor XIa. J Thromb Haemost 2010; 8: 1532–1539.
17. Smith SA, Mutch NJ, Baskar D, et al. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903–908.
18. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011; 118: 6963–6970.
19. Smith SA, Choi SH, Davis-Harrison R, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 2010; 116: 4353–4359.
20. Werner T P, Amrhein N, Freimoser FM. Specific localization of inorganic poly-phosphate (poly P) in fungal cell walls by selective extraction and immunohisto-chemistry. Fungal Genet Biol 2007; 44: 845–852.
21. Morrissey JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981; 117: 307–310.
22. Ruiz FA, Lea CR, Oldfield E, et al. Human platelet dense granules contain poly-phosphate and are similar to acidocalcisomes of bacteria and unicellular euka-ryotes. J Biol Chem 2004; 279: 44250–44257.
23. Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflam-matory and procoagulant mediators in vivo. Cell 2009; 139: 1143–1156.
24. Camire RM. A new look at blood coagulation factor V. Curr Opin Hematol 2011; 18: 338–342.
25. Yang TL, Cui J, Taylor JM, et al. Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression. Thromb Haemost 2000; 83: 70–77.
26. Cui J, O’Shea KS, Purkayastha A, et al. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 1996; 384: 66–68.
27. Keller FG, Ortel TL, Quinn-Allen MA, et al. Thrombin-catalyzed activation of recombinant human factor V. Biochemistry 1995; 34: 4118–4124.
28. Steen M, Dahlback B. Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site. J Biol Chem 2002; 277: 38424–38430.
29. Wood J P, Bunce M W, Maroney SA, et al. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci USA 2013; 110: 17838–17843.
30. Schuijt TJ, Bakhtiari K, Daffre S, et al. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein. Circulation 2013; 128: 254–266.
31. Talbot K, Song J, Hewitt J, et al. A novel compensating mechanism for homozy-gous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V. Br J Haematol 2010; 151: 198–200.
32. Rex S, Beaulieu LM, Perlman DH, et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release. Thromb Haemost 2009; 102: 97–110.
33. Mirlashari MR, Ryningen A, Mikkelsen HM, et al. Differential secretion of blood platelet storage granules. Platelets 1996; 7: 313–320.